The U.S. Food and Drug Administration (FDA) is once again pushing for a recall of homeopathic teething products now that the government agency issued a new report that certain brands contain a toxic substance called belladonna, which comes from the deadly nightshade plant as its hallucinogenic qualities can be poisonous. However, since the first warning the FDA has received more than 400 reports of side effects - including 10 deaths - that could be linked to teething products containing belladonna, according to CNN.

Dr. Janet Woodcock, director of the FDA's Center for Drug Evaluation and Research said that they "recommend that parents and caregivers not give these homeopathic teething tablets to children and seek advice from their health care professional for safe alternatives".

In 2015, Madison Tapler was using Hyland's Baby Nighttime Teething Tablets to treat her baby daughter's pain.

In light of these findings, the FDA contacted Standard Homeopathic Company in Los Angeles, the manufacturer of Hyland's homeopathic teething products, regarding a recall of its homeopathic teething tablet products labeled as containing belladonna, in order to protect consumers from inconsistent levels of belladonna.

Homeopathic teething tablets have been around since the 1900s.

As a result, the FDA urges consumers not to use these homeopathic teething tablets.

Whether these deaths directly relate to teething products "has not yet been determined and is now under review", Meyer added. "The fact is that we have not been made aware of any medical or statistical evidence to support a causal link between homeopathic teething tablets and adverse outcomes at this point". Consumers should stop purchasing these products which can pose a severe threat to their infants' health. Nevertheless, the products' maker, Hyland's, would not agree to recall the products when it was notified of the FDA's conclusion, the agency reported. Hyland's discontinued the product in October. "We continue to request any available information and statistics from the FDA".

In November, Raritan Pharmaceuticals Inc recalled three belladonna-containing homeopathic products, two of which were marketed by CVS Health Corp.